OTC ZOVIRAX PATIENT ASSISTANCE PROGRAM
This article was originally published in The Tan Sheet
Executive Summary
OTC ZOVIRAX PATIENT ASSISTANCE PROGRAM is being considered by Burroughs Wellcome in preparation for the Rx-to-OTC switch of oral acyclovir for the management of recurrent genital herpes, the company told FDA in a recent letter. "Although over-the-counter status will make Zovirax more widely available," Burroughs Wellcome said it recognizes that an Rx-to-OTC switch "may change the ways in which people with limited financial means currently obtain the medication."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning